LILIAN ENEUDE: Open Payments
NPI 1730871120 · DECATUR, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$701 in 19 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $290 · 2025 $701
Food & beverage: $701
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 4 | $262 |
| Neurocrine BioSciences, Inc. | 5 | $201 |
| E.R. Squibb & Sons, L.L.C. | 4 | $130 |
| Teva Pharmaceuticals USA, Inc. | 4 | $72 |
| Otsuka America Pharmaceutical, Inc. | 2 | $36 |
Products named: INVEGA SUSTENNA, INGREZZA, COBENFY, UZEDY, ABILIFY MAINTENA, AUSTEDO XR.
Industry payments across GA — which companies pay providers there.
